When Does Wegovy Start Working — and What Happens First?

The first injection: what you actually feel in week one

You've just given yourself the 0.25mg starter dose, and now you're wondering whether anything is happening at all. That feeling is completely understandable. The first pen's job isn't dramatic weight loss, it's getting your body accustomed to semaglutide so that the stronger doses later don't arrive as a shock.

Most people report something subtle within three to five days: meals feel filling faster, the pull towards a second helping isn't quite as strong, and snacking feels less automatic. Some people notice mild nausea, particularly after eating, which is the most common early sign that the medicine is doing something. For a detailed list of what those early side effects look like and how to manage them, the NHS semaglutide medicines page is the clearest first port of call.

Weight on the scales in week one? Probably not much. A pound or two of fluid shift is possible, but that isn't the target. If you want a clear picture of when Wegovy starts working and what to expect at each stage, it helps to look at the full timeline rather than judging progress by day seven alone. The mechanism is being established, not completed.

Weeks two to eight: the pattern you're building toward

By week four, the prescriber-led titration moves from 0.25mg to 0.5mg. By week eight, it steps to 1.0mg. Each increase tends to bring a fresh wave of appetite reduction, usually settling within a few days. This is the period where most people see their first clear downward movement on the scales, typically one to two pounds a week, though individual variation is wide.

The mechanism behind this is worth understanding. Semaglutide slows gastric emptying, so food genuinely sits in your stomach longer. It also signals satiety to the hypothalamus, the part of the brain that governs hunger. Neither of these effects is instant; they accumulate. You can read about how the drug works at a clinical level on the NHS medicines page, or explore the broader Wegovy overview for context on the full treatment programme.

If week six arrives and you feel nothing at all (no appetite change, no nausea, no shift in eating patterns) that's worth raising with your prescriber rather than assuming it isn't working. It may be a sign that the dose needs re-evaluating, or that something in your routine is blunting absorption. Understanding how soon Wegovy starts working for most people can give you a useful benchmark for that conversation.

Months two to five: where the evidence says most weight loss happens

The STEP 1 trial (the large phase-3 study that underpinned Wegovy's UK licence) ran for 68 weeks and recorded around 15% average body-weight reduction at 2.4mg maintenance dose. What that trial also showed is that the steepest loss curve sits between roughly weeks eight and thirty-two. That's when most participants had reached their maintenance dose and the cumulative effect of sustained appetite suppression was at its strongest.

In practical terms: months two through five are often the most visibly productive. Clothes fit differently. Energy changes. Hunger cues become less intrusive. If you're considering whether to start and want to understand the cost involved before committing, the Wegovy cost guide sets out what private treatment typically involves. The STEP 1 trial results are published in the New England Journal of Medicine for anyone who wants to read the primary data.

Progress isn't linear. A week with no movement on the scales doesn't mean the medicine has stopped. The question of whether Wegovy stops working is a common one and worth understanding properly before drawing conclusions from a single week.

What affects how quickly it works for you

Starting weight, metabolic rate, diet quality, sleep, activity levels and how consistently the injection is given on the same day each week all influence how quickly the effects become visible. The factors shaping Wegovy's timeline are worth reviewing if your progress feels slower than expected.

There's also a practical point about adherence: oral contraceptives may be less reliably absorbed during the early weeks of tirzepatide treatment, but for semaglutide the NHS notes there isn't the same evidence of reduced pill effectiveness. Still, if you take any regular oral medicines, flag them at your consultation, interactions matter and a prescriber can advise.

Under-18s are not licensed for this treatment. It is not recommended during pregnancy, while breastfeeding, or if you are trying to conceive. People with a history of certain thyroid conditions or pancreatitis need a careful prescriber conversation before starting.

If you'd like a prescriber to review your situation and establish whether semaglutide is appropriate for you, you can start a free consultation with the team at nume. A real clinician reads every response the same day.